Literature DB >> 20494325

Vitamin D and multiple sclerosis.

Alberto Ascherio1, Kassandra L Munger, K Claire Simon.   

Abstract

The hypothesis that adequate vitamin D nutrition can contribute to the prevention of multiple sclerosis (MS) was originally proposed to explain the geographical distribution of MS, but only recently has the relation between various measures of vitamin D (eg, sun exposure, dietary sources, and serum concentrations of 25-hydroxyvitamin D) and risk of developing MS been rigorously investigated. Overall, the results of these studies support a protective effect of vitamin D, but there are uncertainties and many unanswered questions, including how vitamin D exerts a protective effect, how genetic variations modify the effect, and whether vitamin D can influence the course of MS progression. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20494325     DOI： 10.1016/S1474-4422(10)70086-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


  155 in total

1.  Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?

Authors:  Fatih Kantarci; Sait Albayram; Nuri Onat Demirci; Asim Esenkaya; Derya Uluduz; Omer Uysal; Sabahattin Saip; Aksel Siva
Journal:  Eur Radiol       Date:  2011-11-29       Impact factor: 5.315

2.  Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.

Authors:  Y Li; K L Munger; S Batool-Anwar; K De Vito; A Ascherio; X Gao
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

3.  Metastatic calcinosis cutis due to refractory hypercalcaemia responsive to denosumab in a patient with multiple sclerosis.

Authors:  Ahmed Jorge; Robert Szulawski; Fnu Abhishek
Journal:  BMJ Case Rep       Date:  2019-02-25

4.  Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis ‬.

Authors:  Manuel Zeitelhofer; Milena Z Adzemovic; David Gomez-Cabrero; Petra Bergman; Sonja Hochmeister; Marie N'diaye; Atul Paulson; Sabrina Ruhrmann; Malin Almgren; Jesper N Tegnér; Tomas J Ekström; André Ortlieb Guerreiro-Cacais; Maja Jagodic
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

Review 5.  The emerging role of vitamin D binding protein in multiple sclerosis.

Authors:  Giulio Disanto; Sreeram V Ramagopalan; Andrea E Para; Lahiru Handunnetthi
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

Review 6.  The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Authors:  Leah J Mische; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2018-03-17       Impact factor: 3.598

Review 7.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 8.  A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis.

Authors:  Beatriz Pozuelo-Moyano; Julián Benito-León; Alex J Mitchell; Jesús Hernández-Gallego
Journal:  Neuroepidemiology       Date:  2012-12-18       Impact factor: 3.282

9.  Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe.

Authors:  E M Brouwer-Brolsma; H A Bischoff-Ferrari; R Bouillon; E J M Feskens; C J Gallagher; E Hypponen; D J Llewellyn; E Stoecklin; J Dierkes; A K Kies; F J Kok; C Lamberg-Allardt; U Moser; S Pilz; W H Saris; N M van Schoor; P Weber; R Witkamp; A Zittermann; L C P G M de Groot
Journal:  Osteoporos Int       Date:  2012-12-11       Impact factor: 4.507

10.  Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.

Authors:  Guler Tosunbayraktar; Murat Bas; Altug Kut; Aylin Hasbay Buyukkaragoz
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.